[1]
Rischin, D., Brungs, D. , Day, F. , Christie, H. , Patel, V., Adams, G. , Estes Jackson, J., De Liz Vassen Schurmann, M., Kirtbaya, D. , Shin, T. , Hart, C., Stankevich, E. , Li, S., Lowy, I. , Han, H. , Gonçalves, P. , Fury, M. and Porceddu, S. 2023. C-POST protocol update: A Phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s173. DOI:https://doi.org/10.25251/skin.7.supp.173.